Carina Biotech is an Australian startup #immunotherapy company developing technologies to target solid #cancer Carina Biotech Pty Ltd is a start-up biotech company focused on research and IP development in T cell immunotherapies, particularly chimeric antigen receptor T cell (CAR-T) technologies.
[atom_linkedin linkedin_option=”CompanyInsider” linkedin_id=”https://www.linkedin.com/company/carina-biotech” connections=”true” suffix=””]
Carina is developing technologies to expand the clinical utility and commercial market for CAR-T cell immunotherapies. Carina is developing injectable gel formulations for the transfer, isolation and controlled delivery of CAR-T cells to solid tumours.
In Apr 2018, Carina Biotech recieved $1 Mn funding from MTPConnect, the Medical Technology, Biotechnology and Pharmaceutical (MTP) Industry Growth Centre.